Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis
Tryptase, a neutral protease, is selectively concentrated in the secretory granules of human mast cells, and its release into the circulation serves as a clinical marker of mast cell activation. The current study describes a new, more sensitive ELISA utilizing a newly developed, mouse monoclonal IgG1 antibody for capture called B12 and capable of detecting tryptase in normal plasma and serum. The greater sensitivity of the new immunoassay results in part from a greater portion of tryptase being detected. Mean levels of tryptase in serum from normal subjects from Richmond, Virginia (4.9 ng/ml;n=56), Munich, Germany (3.8 ng/ml;n=19), and Amersfoort, The Netherlands (1.9 ng/ml;n=8) were as indicated. In 62 subjects with ongoing allergic rhinitis, tryptase levels were no different in serum than for 19 normal controls, indicating that local mast cell activation is not necessarily reflected in the circulation. In 61 subjects sensitive to honey bee or yellow jacket venom by history, the 17 destined to have a severe, hypotensive response to a sting challenge had higher levels of tryptase at baseline than mild reactors, nonreactors, and controls, suggesting that baseline levels of tryptase may predict the severity of the clinical response to allergen in sensitive subjects.
Key wordsTryptase mast cell anaphylaxis allergic rhinitis Hymenoptera sting allergy
Unable to display preview. Download preview PDF.
- 2.Schwartz LB, Huff TF: Biology of mast cells and basophils.In Allergy: Principals and Practice, E Middleton, Jr., CE Reed, EF Ellis, NF Adkinson, Jr., JW Yunginger, WW Busse (eds). St. Louis, Mosby-Year Book, 1993, pp 135–168Google Scholar
- 8.Silvers WS, Essember LJ, Williams PB, Selner JC, Dolen WK: Anaphylaxis due to diclofenac sodium (Voltaren): Evidence of mast cell mediator release. Immunol Allergy Pract 13:193–196, 1991Google Scholar
- 9.Yunginger JW, Nelson DR, Squillace DL, Jones RT, Holley KE, Hyma BA, Biedrzycki L, Sweeney KG, Sturner WQ, Schwartz LB: Laboratory investigation of deaths due to anaphylaxis. J Forens Sci 36:857–865, 1991Google Scholar
- 10.Ownby DR: Anaphylaxis associated with latex allergy during barium enema examinations. Am J Roentgen 156:903–908, 1991Google Scholar
- 11.Watkins J: Tryptase release and clinical severity of anaesthetic reactions. Agents Actions 36 (Suppl C):C203-C205, 1992Google Scholar
- 21.Sedgwick JB, Calhoun WJ, Gleich GJ, Kita H, Abrams JS, Schwartz LB, Volovitz B, Ben-Yaakov M, Busse WW: Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge: Characterization of eosinophil and mast cell mediators. Am Rev Resp Dis 144:1274–1281, 1991PubMedGoogle Scholar
- 27.Atkins PC, Schwartz LB, Adkinson NF, von Allmen C, Valenzano M, Zweiman B: In vivo antigen-induced cutaneous mediator release: Simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administration. J Allergy Clin Immunol 86:360–370, 1990PubMedGoogle Scholar
- 29.Tsubaki T, Iikura Y, Saito H, Akasawa A, Tabana T, Matsuda S, Koshibu T, Iwasaki A, Obata T, Sugihara Y: Changes in histamine/tryptase levels in skin chambers: Application for clinical evaluation of atopic dermatitis. Int Arch Allergy Immunol 99:459–462, 1992Google Scholar
- 32.Proud D, Bailey GS, Naclerio RM, Reynolds CJ, Cruz AA, Eggleston PA, Lichtenstein LM, Togias AG: Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol 89:1098–1110, 1992PubMedGoogle Scholar
- 33.Van Toorenenbergen AW, Van Wijk RG, Vermeulen AM, Zijlstra FJ: Increase of albumin, eosinophil cationic protein, histamine, leukotrienes and mast cell tryptase in nasal lavage fluid after challenge with inhalant allergen extract. Agents Actions 36 (Suppl C):C421-C424, 1992Google Scholar
- 40.Schwartz LB, Bradford TR, Lee DC, Chlebowski JF: Immunologic and physicochemical evidence for conformational changes occurring on conversion of human mast cell tryptase from active tetramer to inactive monomer: Production of monoclonal antibodies recognizing active tryptase. J Immunol 144:2304–2311, 1990PubMedGoogle Scholar